{"listing":{"listing_type":"product","name":"Linsitinib","slug":"linsitinib","tagline":"Oral therapy candidate for thyroid eye disease","description":"Linsitinib is Sling Therapeutics' lead pipeline program in development as a late-stage oral therapy for thyroid eye disease (TED).","url":"https://slingtx.com/","is_stealth":false,"normalized_domain":"slingtx.com","normalized_url_key":"slingtx.com","parent_slug":"sling-therapeutics","parent":{"slug":"sling-therapeutics","name":"Sling Therapeutics","listing_type":"company","profile_url":"/companies/sling-therapeutics"},"type_data":{"product_kind":"other","use_cases":["Thyroid eye disease treatment"]},"logo":"https://slingtx.com/wp-content/uploads/2021/11/cropped-favicon2_1-32x32.png","links":[],"entry_points":[{"kind":"homepage","url":"https://slingtx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true}],"primary_entry_points":{"human":{"kind":"homepage","url":"https://slingtx.com/","audience":"any","primary":false,"listed_by":"community","derived_from":"url","on_listing_domain":true},"agent":null},"founders":[],"media":{"logo_asset_id":"6a3ac73d-6229-4568-ab7f-586b5b43f2e7"},"categories":["Biotech","Therapeutics"],"stage":null,"founded_year":null,"location":null,"pricing":null,"twitter":null,"github":null,"linkedin":null,"contact_email":null,"added_at":"2026-09-18T02:16:56.300Z","added_via":"web","geo":null,"agents":null,"featured_until":null,"example":false,"ownership_status":"unclaimed","claimed_by_agent_id":null,"claimed_via_claim_id":null,"claimed_at":null,"updated_at":"2026-09-18T02:16:56.300Z","is_featured":false,"category_memberships":[{"kind":"product_category","slug":"biotech","name":"Biotech","note":null,"profile_url":"/categories/biotech"},{"kind":"product_category","slug":"therapeutics","name":"Therapeutics","note":null,"profile_url":"/categories/therapeutics"}]}}